Huadao Biology
Latest round
- Series D
Last raised
- Oct 2025
Total raised
- $31M
Investors
- 15
About Huadao Biology
Based in Shanghai, China, and established in 2017, Huadao Biology is a cellular immunity therapy technology provider that focuses on R&D of cell therapy drugs and industry chain production technology. The company is a high-tech biomedicine enterprise. Also, it is the only CAR-T cell drug R&D company with independent intellectual property rights in China. The company is building cell drug R&D and transformation production bases in six central cities in China. The company developed the CAR-T cell products industry chain production system, which includes engineered bacteria fermentation, plasmid purification, virus packaging, virus purification, T cell acquisition, T cell transfection, and freezing. Up to 2021, it has carried out R&D of nearly 30 cases of CD19- CAR-T in the treatment of acute lymphoblastic leukemia and non-Hodgkin’s lymphoma. Also, it developed the preclinical cytlogy of CAR vectors for other tumors, such as gastric cancer, liver cancer, pancreatic cancer, and glioma. The company plans to build Huadao Biology Songjiang base phase II project. Also, it will compete HD CD19 CAR-T injection phase II clinical trial.
Who invested in Huadao Biology
15 investors across 5 rounds
See all investors in Huadao Biology
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Huadao Biology
Who invested in Huadao Biology?
Huadao Biology has 15 investors on record across 5 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Huadao Biology raised?
Huadao Biology has raised 5 venture rounds. Sign up free to see how much each round raised and the total.
When did Huadao Biology last raise money?
Huadao Biology's most recent round on record is a Series D, in Oct 2025.
What does Huadao Biology do?
Based in Shanghai, China, and established in 2017, Huadao Biology is a cellular immunity therapy technology provider that focuses on R&D of cell therapy drugs and industry chain production technology.
Where is Huadao Biology headquartered?
Huadao Biology is headquartered in Shanghai, China.
Which VCs invest in companies like Huadao Biology?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Hui Hua Fund, Yufu Capital and ICBC Capital Management back biotechnology companies at Huadao Biology's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series D
Raising like Huadao Biology? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.